Oct 29 (Reuters) - MedCap AB MEDCAP.ST :
* Q3 NET SALES AMOUNTED TO SEK 202.3 (175.4) MILLION, AN
INCREASE
OF 15%
* Q3 EBITDA WAS SEK 49.5 (35.1) MILLION, AN INCREASE OF 41%
* POSITIVE DEVELOPMENT WAS DRIVEN BY MEDTECH BUSINESS AREA,
WHICH
SHOWED STRONG GROWTH WITH GOOD PROFITABILITY
* ALL COMPANIES IN BUSINESS AREA CONTRIBUTED TO INCREASE IN
SALES
AND EARNINGS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr7DG9y2
Further company coverage: MEDCAP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))